Form 4: Lemaitre Vascular Director Reports Equity Changes
Insider Transaction Report
Lemaitre Vascular Director John James O'Connor reported a gift of 3,000 common shares and the acquisition of one share linked to dividend equivalent rights.
Summary
- John James O'Connor, a Director of Lemaitre Vascular Inc. (LMAT), reported changes in his beneficial ownership.
- On December 4, 2025, O'Connor disposed of 3,000 shares of common stock via a gift (transaction code 'G') at a price of $0.
- Following this disposition, O'Connor's direct beneficial ownership of common stock was 61,801 shares.
- On December 6, 2025, O'Connor acquired 1 share of common stock (transaction code 'M') at a price of $0, representing shares acquired upon the release of dividend equivalent rights.
- After all reported transactions, O'Connor's direct beneficial ownership of common stock increased to 61,802 shares.
- Multiple dividend equivalent rights (DERs) accrued on December 4, 2025, tied to restricted stock unit (RSU) and performance share unit (PSU) awards granted on December 12, 2022, December 8, 2023, and December 6, 2024.
- These DERs vest proportionately with their underlying awards, with each DER being the economic equivalent of one share of common stock.
- On December 6, 2025, 1 dividend equivalent right was released in connection with the vesting of an RSU award granted on December 6, 2024.
Sentiment
Score: 4
Explanation: The sentiment is slightly negative due to the disposition of 3,000 shares, even though it was a gift. While there was an acquisition of 1 share and accrual of dividend equivalent rights, the net direct share ownership decreased from the disposition.
Positives
- Accrual of additional dividend equivalent rights (DERs) on existing restricted stock unit (RSU) and performance share unit (PSU) awards, increasing potential future share count.
- Acquisition of 1 common share due to the vesting and release of dividend equivalent rights, indicating progress on existing equity compensation.
Negatives
- Disposition of 3,000 shares of common stock via a gift, reducing the director's direct ownership stake in the company.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Minor impact due to routine insider share transactions. The gift of shares reduces the director's direct stake, which could be perceived neutrally or slightly negatively depending on investor perspective.
Key Dates
| Date | Description |
|---|---|
| 12/12/2022 | Grant date for restricted stock unit and performance share unit awards on which dividend equivalent rights accrued. |
| 12/08/2023 | Grant date for restricted stock unit and performance share unit awards on which dividend equivalent rights accrued. |
| 12/06/2024 | Grant date for a restricted stock unit award on which dividend equivalent rights accrued and were subsequently released. |
| 12/04/2025 | Date of disposition of 3,000 common shares and acquisition of multiple dividend equivalent rights. |
| 12/06/2025 | Date of acquisition of 1 common share and release of 1 dividend equivalent right. |
| 12/08/2025 | Signature date of the reporting person's attorney-in-fact. |
Keywords
Lemaitre Vascular, LMAT, Form 4, Insider Transaction, Beneficial Ownership, Director, Equity, Common Stock, Dividend Equivalent Rights, RSU, PSU, Gift
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.